HDL Cholesterol: Metabolic Pathways and Drug Developments Fifth Annual International Conference of the Knowledge Foundation March 8 — 9, 2004, Cambridge, MA USA

Saved in:
Bibliographic Details
Published in:Cardiovascular drug reviews 2004, Vol.22 (2), p.147-153
Main Author: Scriabine, Alexander
Format: Article
Language:English
Subjects:
Animals
Anticholesteremic Agents - pharmacology
Anticholesteremic Agents - therapeutic use
Arteriosclerosis - etiology
Arteriosclerosis - prevention & control
Atherosclerosis
Cardiovascular Diseases - etiology
Cardiovascular Diseases - prevention & control
Cholesterol transport
Cholesterol, HDL - metabolism
HDL cholesterol
HDL‐C‐raising drugs
Humans
Hyperlipidemias - complications
Hyperlipidemias - drug therapy
Hyperlipidemias - metabolism
Lipoprotein metabolism
Metabolic syndrome
Nuclear receptors
Scavenger receptor B
Citations: Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0897-5957
1527-3466
DOI:10.1111/j.1527-3466.2004.tb00137.x